Phase I study ofMRX34, a liposomalmiR-34a mimic,administered twiceweekly in patientswith advanced solidtumors Muhammad S. BegAndrew BrennerJasgit C. Sachdev2016 год

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
статья из журнала